The Asia-Pacific drug discovery informatics market is projected to grow at a significant CAGR of 10.8% during the forecast period (2020-2026). The growing demand for cloud-based solutions in the pharmaceutical sector in various countries such as China, India, and Japan further provide a significant opportunity to the drug discovery informatics market in the region. The significant adoption of the NGS technologies for clinical research further increases the need for cloud technologies. The increasing presence of major cloud service providers, including IBM Corp. and Microsoft Corp. will likely offer an opportunity to accelerate demand for cloud platforms coupled with informatics tools in the emerging pharmaceutical industry in the region.
Browse the full report description Asia-Pacific Drug Discovery Informatics Market Size, Share & Trends Analysis Report by Function (Docking, Molecular Modeling, Libraries & Database Preparation, Sequencing & Target Data Analysis, and Others), by End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Others) and Forecast 2020-2026 at https://www.omrglobal.com/industry-reports/asia-pacific-drug-discovery-informatics-market
Moreover, the integration of AI technology in the healthcare sector in the region further provides substantial opportunity to the drug discovery informatics market. For instance, in January 2018, the Government of China has planned to invest $2.12 billion in the development of an AI technology park near Beijing. The park aims to promote companies working in the field of big data, deep learning, and cloud computing. Alibaba Group is one of the major players working in the field of medical cloud computing and AI in the country. In 2016, Alibaba Cloud team up with Intel and BGI Genomics to initiate a bioinformatics analysis platform that will be able to sequence the entire human genome within a day.
Market Coverage
|
Report Elements |
Details |
|
Study Period |
2019-2026 |
|
Base year |
2019 |
|
Forecast period |
2020-2026 |
|
Segments Covered |
By Function and by End-User |
|
Regions Covered |
China, India, Japan, and the Rest of Asia-Pacific |
|
Key Companies Profiled |
Accenture PLC,
Eurofins GSC Lux SARL, Jubilant Life Science, Novo Informatics Pvt. Ltd.,
Infosys Ltd., and others |
Key questions addressed by the report
o Recovery Timeline
o Deviation from the pre-COVID-19 forecast
o Most affected region/segment
o Recommendations
Asia-Pacific Drug Discovery Informatics Market – Segmentation
By Function
By End-User
Asia-Pacific Drug Discovery Informatics Market – Segmentation by Geography
To learn more about this report request a free sample copy
@ https://www.omrglobal.com/request-sample/asia-pacific-drug-discovery-informatics-market